Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-10-31
1999-12-07
Harrison, Robert H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514565, 514682, 514895, A61K 3115, A61K 31155
Patent
active
05998449&
ABSTRACT:
The invention relates to combinations of atovaquone and proguanil, their use in the treatment and propinylaxis of parasitic infections, such as protozoal parasitic infections, e.g. malaria and toxoplasmosis, and infections caused by P.carinii and their use in the manunfacture of medicaments for the treatment and/or prophylaxis of such infections. The combinations can conveniently be administered in a single pharmaceutical formulation. Preferably, atovaquone and proguanil are administered in a potentiating ratio so that they act in synergy.
REFERENCES:
patent: 2533648 (1950-12-01), Fieser et al.
patent: 3347830 (1967-10-01), Rogers
patent: 3367742 (1968-02-01), Sarett
patent: 3674872 (1972-07-01), Rheiner, Jr. et al.
patent: 4981874 (1991-01-01), Latter et al.
patent: 5053418 (1991-10-01), Latter et al.
patent: 5053432 (1991-10-01), Hudson et al.
patent: 5206268 (1993-04-01), Latter et al.
patent: 5225184 (1993-07-01), Latter et al.
patent: 5310762 (1994-05-01), Latter et al.
patent: 5641769 (1997-06-01), Remington et al.
patent: 5744168 (1998-04-01), Fitzgerald
patent: 5827543 (1998-10-01), Fitzgerald
C.P.J. Ash, "Fourth Malaria Meeting", Parasitology Today, vol. 8, No. 8, issued Aug. 1992, pp. 252-255.
Wofsy, pp. 377-401, Chapter 36, 1986.
Fieser, et al., vol. 70, pp. 3156-3165, 1948.
Hughes, Parasitology Today, vol. 3,, No. 11, pp. 332-335, 1887.
Parsons, 10 pages, issued Aug. 7, 1989.
Discriminant Analysis and Structure-Activity Relationships 1. Naphthoquinone; J. Med. Chem; vol. 21; No. 4; 1978; pp. 369-374.
Role Of The Naphthoquinone Moiety In The Biological Activities Of Sakyomicin A: J. Antibiot. vol. 39; No. 4; 1986; pp. 557-563.
Inhibition Of Thioredoxin Reductase (E.C. 1.6.4.5) By Antitumor Quinones; Free Fad. Res. Commun. vol. 8; No. 4-6; 1990; pp. 365-372.
Parasitol. Today, vol. 8, No. 8, pp. 252-255, C.P.J. Ash "Fourth malaria meeting" Aug. 1992.
Parasitol. Today; vol. 9, No. 2, pp. 66-68, A.T. Hudson "Atovaquone--a novel broad-spectrum anti-infective drug".
Abstract and Poster by M. Pudney et al. presented a VIII International Congress of Protozoology, Jul. 10-17, Tsukuba, Japan, 1992.
Shargel et al Applied Biopharmaceutics and Pharmacokinetics, 2.sup.nd Edition Appleton-Century-Crofts, 1985.
Gutteridge Winston Edward
Hutchinson David Brian Ashton
Latter Victoria Susan
Pudney Mary
Glaxo Wellcome Inc.
Harrison Robert H.
LandOfFree
Combination of atovaquone with proguanil for the treatment of pr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of atovaquone with proguanil for the treatment of pr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of atovaquone with proguanil for the treatment of pr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-824360